2008 -2013 Senior SEC Reporting and Finance Manager @ MAP Pharmaceuticals (acquired by Allergan Inc. in 2013)
2005 -2008 External Reporting Manager @
2002 -2005 Senior External Reporting Analyst @ Nuance Communications (acquired by Scansoft Inc. in 2005)
2001 -2002 Financial Reporting Analyst - level II @
Mei Wang Education
Guangzhou University of Foreign Languages and Foreign Trade
Concordia University, John Molson School of Business
Univ Of Nc Hosps, Internal Medicine
Mei Wang Skills
Reporting
Securities and Exchange Commission
Finance
Mei Wang Summary
Mei Wang, based in Cupertino, CA, US, is currently a Director, SEC Reporting and Technical Accounting at CytomX Therapeutics. Mei Wang brings experience from previous roles at PRE-IPO NETWORK COMPANY (aiming to go IPO through SPAC by filing S-4), Pacific Biosciences, MAP Pharmaceuticals (acquired by Allergan Inc. in 2013) and Blue Coat Systems acquired by Symantec. Mei Wang holds a Guangzhou University of Foreign Languages and Foreign Trade. With a robust skill set that includes Reporting, Securities and Exchange Commission, Finance and more. Mei Wang has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mei Wang?
Find contact details for 700 million professionals.